Skip to main content
Equibles

Stone House Investment Management, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1696497 TUNKHANNOCK, PA
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$38,744
+$1,682 QoQ
Shares Held
78
-6.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,558
of 1,746 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Stone House Investment Management, LLC holds $550,462 across 71 Biotechnology names. VRTX ranks #6 (7.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AUPH
Aurinia Pharmaceuticals Inc.
 6,693 $113,580
2 ORKA
Oruka Therapeutics, Inc.
 902 $85,843
3 TGTX
Tg Therapeutics, Inc.
 1,008 $55,379
4 INSM
INSMED Inc
 501 $53,416
5 DFTX
Definium Therapeutics, Inc.
 1,000 $47,040
6 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		78 $38,744
7 VKTX
Viking Therapeutics, Inc.
 800 $31,208
8 STOK
Stoke Therapeutics, Inc.
 500 $16,360

All Filings in VRTX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,744 78
2026-03-31 $37,062 83
2025-12-31 $34,908 77
2025-09-30 $29,373 75
2025-06-30 $32,944 74
2025-03-31 $47,997 99
2024-09-30 $57,669 124
2024-06-30 $58,121 124
2024-03-31 $51,833 124
2023-12-31 $50,454 124
2023-09-30 $43,119 124
2023-06-30 $43,636 124
2023-03-31 $39,068 124